HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
HTGM
Delisted
HTGM was delisted on the 14th of June, 2023.
54 hedge funds and large institutions have $67M invested in HTG Molecular Diagnostics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
23% more funds holding
Funds holding: 44 → 54 (+10)
Holders
54
Holding in Top 10
–
Calls
$61K
Puts
$3K
Top Buyers
| 1 | +$1.09M | |
| 2 | +$1.04M | |
| 3 | +$1.01M | |
| 4 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$1.01M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$505K |
Top Sellers
| 1 | -$5.82M | |
| 2 | -$1.7M | |
| 3 | -$978K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$728K |
| 5 |
SIM
Spark Investment Management
New York
|
-$663K |